<?xml version="1.0" encoding="UTF-8"?>
<document id="27872092">
	<sentence id="s1" text="The polo family serine threonine kinase protein phosphorylation has been proposed as a therapeutic target in advanced cancers based on increased expression in primary human cancers, facilitation of tumor growth in murine xenograft models, and centrosomal amplification induced by its overexpression.">
		<entity id="s1.e1" charOffset="40-63"
			type="GO" text="protein phosphorylation" ontology_id="GO_0006468"/>
		<entity id="s1.e2" charOffset="118-124"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s1.e3" charOffset="198-203"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e3" pgr="false"/>
		<pair id="s1.p2" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Here we characterize protein phosphorylation-dependent cancer cell migration and invasion as well as local invasion and metastasis of cancer xenografts.">
		<entity id="s2.e1" charOffset="21-44"
			type="GO" text="protein phosphorylation" ontology_id="GO_0006468"/>
		<entity id="s2.e2" charOffset="55-61"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="protein phosphorylation depletion suppressed cancer invasion and induced an epithelial phenotype in poorly differentiated breast cancer cells.">
		<entity id="s3.e1" charOffset="0-23"
			type="GO" text="protein phosphorylation" ontology_id="GO_0006468"/>
		<entity id="s3.e2" charOffset="45-51"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
	<sentence id="s4" text="In an unbiased BioID screen for protein phosphorylation interactors, we identified members of the Arp2/3 complex-mediated actin nucleation/3 complex and confirmed a physical and functional interaction between Plk4 and Arp2 in mediating Plk4-driven cancer cell movement.">
		<entity id="s4.e1" charOffset="32-55"
			type="GO" text="protein phosphorylation" ontology_id="GO_0006468"/>
		<entity id="s4.e2" charOffset="98-138"
			type="GO" text="Arp2/3 complex-mediated actin nucleation" ontology_id="GO_0034314"/>
		<entity id="s4.e3" charOffset="212-218"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e3" pgr="false"/>
		<pair id="s4.p2" e1="s4.e2"
		    e2="s4.e3" pgr="false"/>
	</sentence>
	<sentence id="s5" text="Our results validate protein phosphorylation as a therapeutic target in cancer patients and reveal a new role for Plk4 in regulating Arp2/3 complex-mediated actin nucleation/3-mediated actin cytoskeletal rearrangement.">
		<entity id="s5.e1" charOffset="21-44"
			type="GO" text="protein phosphorylation" ontology_id="GO_0006468"/>
		<entity id="s5.e2" charOffset="72-78"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s5.e3" charOffset="133-173"
			type="GO" text="Arp2/3 complex-mediated actin nucleation" ontology_id="GO_0034314"/>
		<pair id="s5.p1" e1="s5.e1"
		    e2="s5.e2" pgr="false"/>
		<pair id="s5.p2" e1="s5.e2"
		    e2="s5.e3" pgr="false"/>
	</sentence>
</document>
